Antibodies that bind to interleukin-22
US7279559B2 · kind B2 · utility
13Cited by
11References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2002 |
| Grant date | Oct 9, 2007 |
| Priority date | — |
| Expiry date | Aug 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.